Teng_2015_Biochem.Pharmacol_97(4)_518

Reference

Title : UBXN2A regulates nicotinic receptor degradation by modulating the E3 ligase activity of CHIP - Teng_2015_Biochem.Pharmacol_97(4)_518
Author(s) : Teng Y , Rezvani K , De Biasi M
Ref : Biochemical Pharmacology , 97 :518 , 2015
Abstract :

Neuronal nicotinic acetylcholine receptors (nAChRs) containing the alpha3 subunit are known for their prominent role in normal ganglionic transmission while their involvement in the mechanisms underlying nicotine addiction and smoking-related disease has been emerging only in recent years. The amount of information available on the maturation and trafficking of alpha3-containing nAChRs is limited. We previously showed that UBXN2A is a p97 adaptor protein that facilitates the maturation and trafficking of alpha3-containing nAChRs. Further investigation of the mechanisms of UBXN2A actions revealed that the protein interacts with CHIP (carboxyl terminus of Hsc70 interacting protein), whose ubiquitin E3 ligase activity regulates the degradation of several disease-related proteins. We show that CHIP displays E3 ligase activity toward the alpha3 nAChR subunit and contributes to its ubiquitination and subsequent degradation. UBXN2A interferes with CHIP-mediated ubiquitination of alpha3 and protects the nicotinic receptor subunit from endoplasmic reticulum associated degradation (ERAD). UBXN2A also cross-talks with VCP/p97 and HSC70/HSP70 proteins in a complex where alpha3 is likely to be targeted by CHIP. Overall,we identify CHIP as an E3 ligase for alpha3 and UBXN2A as a protein that may efficiently regulate the stability of CHIP's client substrates.

PubMedSearch : Teng_2015_Biochem.Pharmacol_97(4)_518
PubMedID: 26265139

Related information

Citations formats

Teng Y, Rezvani K, De Biasi M (2015)
UBXN2A regulates nicotinic receptor degradation by modulating the E3 ligase activity of CHIP
Biochemical Pharmacology 97 :518

Teng Y, Rezvani K, De Biasi M (2015)
Biochemical Pharmacology 97 :518